Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
62.93
-6.24 (-9.02%)
At close: Mar 30, 2026, 4:00 PM EDT
63.00
+0.07 (0.11%)
After-hours: Mar 30, 2026, 7:58 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 21 analysts that cover Boston Scientific stock have a consensus rating of "Strong Buy" and an average price target of $104.48, which forecasts a 66.03% increase in the stock price over the next year. The lowest target is $88 and the highest is $128.
Price Target: $104.48 (+66.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 9 | 9 | 9 |
| Buy | 10 | 9 | 10 | 11 | 12 | 12 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 17 | 18 | 20 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $115 | Buy | Reiterates | $115 | +82.74% | Mar 30, 2026 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $97 → $88 | Strong Buy → Buy | Downgrades | $97 → $88 | +39.84% | Mar 30, 2026 |
| Needham | Needham | Strong Buy Reiterates $97 | Strong Buy | Reiterates | $97 | +54.14% | Mar 30, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $98 → $93 | Strong Buy | Maintains | $98 → $93 | +47.78% | Mar 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $110 → $90 | Strong Buy | Maintains | $110 → $90 | +43.02% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
22.49B
from 20.07B
Increased by 12.02%
Revenue Next Year
24.83B
from 22.49B
Increased by 10.41%
EPS This Year
3.50
from 1.94
Increased by 80.25%
EPS Next Year
3.96
from 3.50
Increased by 13.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.9B | 26.4B | |||
| Avg | 22.5B | 24.8B | |||
| Low | 21.6B | 23.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.8% | 17.4% | |||
| Avg | 12.0% | 10.4% | |||
| Low | 7.8% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.66 | 4.20 | |||
| Avg | 3.50 | 3.96 | |||
| Low | 3.35 | 3.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 88.9% | 20.1% | |||
| Avg | 80.3% | 13.2% | |||
| Low | 72.8% | 5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.